BHVN - Biohaven Ltd.

QQQ $ 604.88 $ 0.00 (0 %)

DIA $ 463.30 $ 0.00 (0 %)

SPY $ 667.07 $ 0.00 (0 %)

TLT $ 91.07 $ 0.00 (0 %)

GLD $ 390.50 $ 0.00 (0 %)

Previous Close

$ 17.36

Open

$ 16.63

Bid

$ 17.37 x 5

Ask

$ 17.55 x 1

Day's Range

-- - --

52 Week Range

$ 12.79 - $ 54.98

Volume

2,877,432

Average Volume

Market Cap

1.18B

Beta (5Y Monthly)

$ 1.96

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-11-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	03-03-2025	01-01-1970	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-09-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-14-2023	09-30-2023	10-Q
9	07-31-2023	06-30-2023	10-Q
10	05-12-2023	03-31-2023	10-Q
11	03-23-2023	12-31-2022	10-K
12	11-09-2022	09-30-2022	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

10 Health Care Stocks With Whale Alerts In...
09/29/2025 17:35:29

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and...

this-protagonist-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday

This Protagonist Therapeutics Analyst Begi...
09/17/2025 12:15:15

Citigroup Initiates Coverage On Biohaven w...
09/17/2025 11:30:06

Citigroup analyst Samantha Semenkow initiates coverage on Biohaven (NYSE:BHVN) with a Buy rating and announces Price Target ...

UBS Maintains Buy on Biohaven, Lowers Pric...
09/16/2025 12:43:46

UBS analyst Ashwani Verma maintains Biohaven (NYSE:BHVN) with a Buy and lowers the price target from $27 to $26.

Raymond James Initiates Coverage On Biohav...
09/03/2025 16:44:36

Raymond James analyst Chris Raymond initiates coverage on Biohaven (NYSE:BHVN) with a Strong Buy rating and announces Price ...

biohaven-advances-toward-potential-first-fda-approved-therapy-for-spinocerebellar-ataxia-fda-drops-advisory-meeting

Biohaven Advances Toward Potential First F...
08/22/2025 13:14:12

Biohaven shares rise as FDA removes advisory committee meeting for troriluzole in spinocerebellar ataxia, with decision expecte...

12 Health Care Stocks Moving In Friday's P...
08/22/2025 12:08:33

FDA Review Of Biohaven's Troriluzole NDA M...
08/22/2025 11:06:24

BTIG Maintains Buy on Biohaven, Raises Pri...
08/19/2025 14:12:48

BTIG analyst Thomas Shrader maintains Biohaven (NYSE:BHVN) with a Buy and raises the price target from $59 to $60.

Biohaven Files Prospectus Related To Regis...
08/15/2025 21:44:18

-SEC Filing

Leerink Partners Maintains Outperform on B...
08/12/2025 22:03:13

Leerink Partners analyst Marc Goodman maintains Biohaven (NYSE:BHVN) with a Outperform and lowers the price target from $60 ...

Morgan Stanley Maintains Overweight on Bio...
08/12/2025 12:22:22

Morgan Stanley analyst Terence Flynn maintains Biohaven (NYSE:BHVN) with a Overweight and lowers the price target from $63 t...

B of A Securities Maintains Buy on Biohave...
08/12/2025 11:47:09

B of A Securities analyst Jason Gerberry maintains Biohaven (NYSE:BHVN) with a Buy and lowers the price target from $50 to $49.

Baird Maintains Outperform on Biohaven, Lo...
08/12/2025 11:38:47

Baird analyst Brian Skorney maintains Biohaven (NYSE:BHVN) with a Outperform and lowers the price target from $57 to $52.

HC Wainwright & Co. Maintains Buy on Bioha...
08/12/2025 11:25:20

HC Wainwright & Co. analyst Douglas Tsao maintains Biohaven (NYSE:BHVN) with a Buy and lowers the price target from $54 ...

Biohaven Q2 Adj. EPS $(1.63) Beats $(1.72)...
08/11/2025 11:10:58

Biohaven (NYSE:BHVN) reported quarterly losses of $(1.63) per share which beat the analyst consensus estimate of $(1.72) by 5.2...

12 Health Care Stocks Moving In Wednesday'...
07/30/2025 17:07:24

teradyne-littelfuse-marvell-technology-cheesecake-factory-and-other-big-stocks-moving-higher-on-wednesday

Teradyne, Littelfuse, Marvell Technology, ...
07/30/2025 14:47:26

JP Morgan Maintains Overweight on Biohaven...
06/18/2025 12:33:07

JP Morgan analyst Tessa Romero maintains Biohaven (NYSE:BHVN) with a Overweight and lowers the price target from $68 to $55.

Bexorg Announces Multi-Program Research Co...
06/10/2025 18:01:39

Bexorg, Inc., a pioneering techbio company working to decode the human brain and advance new therapies for central nervous syst...